Oncotarget cover image

New Insights into HER2-Mutated Non-Small Cell Lung Cancer in Brazil

Oncotarget

00:00

Treatment Access and Real-World Therapies

The podcast highlights limited access: only one patient received trastuzumab-deruxtecan; others had standard treatments.

Play episode from 03:07
Transcript

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app